|
Central Mechanisms in Speech Motor Control Studied with H215O PET Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Central Mechanisms in Speech Motor Control Studied with H215O PET conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Central Mechanisms in Speech Motor Control Studied with H215O PET Clinical research trials and Central Mechanisms in Speech Motor Control Studied with H215O PET healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Central Mechanisms in Speech Motor Control Studied with H215O PET. Central Mechanisms in Speech Motor Control Studied with H215O PET Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Central Mechanisms in Speech Motor Control Studied with H215O PET clinical trial. Human subjects often receive the most effective healthcare possible for their Central Mechanisms in Speech Motor Control Studied with H215O PET condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Central Mechanisms in Speech Motor Control Studied with H215O PET  Central Mechanisms in Speech Motor Control Studied with H215O PET
Central Mechanisms in Speech Motor Control Studied with H215O PET
For Condition: Communication Disorder,Healthy,Stuttering,Tourette Syndrome,Voice Disorder
Status: Recruiting
Sponsor(s): National Institute on Deafness and Other Communication Disorders (NIDCD) ,
Synopsis: Positron Emission Tomography (PET) is a technique used to investigate the functional activity of the brain. The PET technique allows doctors to study the normal biochemical and metabolic processes of the central nervous system of normal individuals and patients with neurologic illnesses without physical / structural damage to the brain. Radioactive water H215O in PET scans permits good visualization of areas of the brain related to speech. Most of the PET scan studies conducted have concentrated on learning about how language is formed and decoded. Few studies have been conducted on speech production. This study aims to use radioactive water (H215O) and Positron Emission Tomography (PET scan) to measure blood flow to different areas of the brain in order to better understand the mechanisms involved in speech motor control. When a region of the brain is active, it uses more fuel in the form of oxygen and sugar (glucose). As the brain uses more fuel it produces more waste products, carbon dioxide and water. Blood carries fuel to the brain and waste products away from the brain. As brain activity increases blood flow to and from the area of activity increases also. Knowing these facts, researchers can use radioactive chemicals (H215O) and PET scans to observe what areas of the brain are receiving more blood flow. Researchers will ask patients to perform tasks that will affect speech, voice, and language. At the same time patients will undergo a PET scan. The tasks are designed to help researchers observe the blood flow to brain areas associated with voicebox (laryngeal) functions, movement of muscles in the jaw, tongue, and mouth, and other aspects of motor speech. Special studies will be conducted to evaluate how certain therapies and tasks can draw out symptoms in illnesses in which speech and language are affected. Results of these tests will be used in other studies to evaluate the neurologic mechanisms of diseases like Tourette's syndrome and parkinson's disease.
Details: The H215O PET, fMRI, and EEG neuroimaging method will be used to study the CNS mechanisms involved in speech production. Sets of controlled tasks intended to isolate and activate distinct elements of motor speech and voice will be administered to normal controls and patients with speech disorders. Tasks will be designed to produce sustained motor behaviors over the 4 minute period of H215O uptake. Individual scans will generally be performed during each task condition. Arterial blood will be sampled to permit full quantification of the PET data. Generalized tasks will be administered both to normal controls and patients with neurological disorders affecting speech, voice and language. These tasks are designed to evaluate the regional cerebral blood flow patterns associated with elementary laryngeal functions, oral, lingual and jaw movements, as well as linguistic and non-linguistic speech production. Other generalized tasks will evaluate prosodic and affective elements of motor speech, premotor mechanisms in speech motor control and regional cerebral blood flow correlates of speech learning. A separate series of studies will evaluate therapeutic interventions or behavioral tasks designed to attenuate symptoms in illnesses in which speech and language are affected. These will be utilized in a repeated measures design to evaluate CNS mechanisms underlying dysfluency in patients with stuttering, and limb vs. speech motor symptoms in Tourette's syndrome, Parkinson's disease and other neurological disorders.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Subjects will be selected from a population of patients with post-stroke aphasia. No preference or exclusion will be granted due to gender, religion, race or ethnic background. Non-pregnant, non-breast feeding, age and sex matched normal subjects will be recruited to provide control values. Recruitment will be limited to those 18 years to 80 years in age. EXCLUSION CRITERIA: Children will be excluded form this protocol because they do not represent members of the population at risk. Pregnant women are excluded because the effects of the MRI on the fetus have not been established.
Total Enrollment: 557
Location and Contact Information:
National Institute on Deafness and Other Communication Disorders (NIDCD) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 920178; 92-DC-0178
Study Start Date: April 28, 1992
Record last reviewed: April 9, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001308
Other Healthy Studies:
1. Central Mechanisms in Speech Motor Control Studied with H215O PET
Related Studies:
Other Healthy Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Central Mechanisms in Speech Motor Control Studied with H215O PET
|
|
|
|
|
|
|
|
